Immunocore to present at upcoming investor conferences

Rhea-AI Summary

Immunocore (Nasdaq: IMCR) announced management will present at multiple investor conferences in March 2026, including TD Cowen (Mar 3), Leerink (Mar 9), Barclays (Mar 10), UBS Biotech Summit (Mar 10) and Jefferies Biotech on the Beach (Mar 11).

Where relevant, presentations will be webcast live via the company’s Investors > Events & Presentations page, with replays available for a limited time.

News Market Reaction – IMCR

-0.95%

-0.95% Session close to close

In the Mar 3 session, IMCR declined 0.95%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Immunocore to present at upcoming investor conferences

(OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 03 March 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced management will participate at the following conferences in March.

        TD Cowen 46^th Annual Healthcare Conference
        Presentation: Tuesday, March 3, 2026, at 2:30 p.m. EST

        Leerink 2026 Global Healthcare Conference
        Fireside Chat: Monday, March 9, 2026, at 3:40 p.m. EST

        Barclays 28^th Annual Global Healthcare Conference
        1x1s and small group meetings: Tuesday, March 10, 2026

        UBS Biotech Summit Miami, Catalyst for Change
        1x1s and small group meetings: Tuesday, March 10, 2026

        Jefferies 2026 Biotech on the Beach Summit
        1x1s and small group meetings: Wednesday, March 11, 2026

Where relevant, the presentations will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’ section of Immunocore’s website at www.immunocore.com. Following the event, a replay of the presentations will be made available for a limited time.

About Immunocore

Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, autoimmune diseases and infectious diseases. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including clinical and pre-clinical programs​ in oncology, infectious diseases, and autoimmune diseases. The Company’s most advanced oncology TCR therapeutic, KIMMTRAK, has been approved for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in the United States, European Union, Canada, Australia, and the United Kingdom.

Contact Information

Immunocore

Sébastien Desprez, Head of Communications
T: +44 (0) 7458030732
E: sebastien.desprez@immunocore.com
Follow on LinkedIn: @Immunocore

Investor Relations

Morgan Morse
T: +1 (215) 384-4781
E: ir@immunocore.com

FAQ

When will Immunocore (IMCR) present at the TD Cowen 46th Annual Healthcare Conference?

Immunocore will present on Tuesday, March 3, 2026 at 2:30 p.m. EST. According to the company, management will deliver a presentation and it may be webcast live via the Investors > Events & Presentations page, with a replay afterward.

How can investors watch Immunocore (IMCR) presentations at the March 2026 conferences?

Investors can watch via the company’s investor site under Events & Presentations. According to the company, where relevant the presentations will be webcast live and a replay will be made available for a limited time after each event.

What events will Immunocore (IMCR) attend during March 9–11, 2026?

Immunocore management will attend Leerink on March 9, Barclays and UBS meetings on March 10, and Jefferies on March 11. According to the company, engagements include a fireside chat, presentations, 1x1s and small group meetings.

Will Immunocore (IMCR) provide replays of the March 2026 conference presentations?

Yes — a replay will be made available for a limited time after each presentation. According to the company, replays can be accessed via the investor website under Events & Presentations following the live webcast when applicable.

Which types of meetings will Immunocore (IMCR) hold at Barclays and Jefferies conferences in March 2026?

Immunocore will hold 1x1s and small group meetings at Barclays (Mar 10) and Jefferies (Mar 11). According to the company, these sessions are part of the firm’s March investor engagement schedule and may not all be webcast.